COMMUNIQUÉS West-GlobeNewswire
-
Zealand Pharma announces initiation of the Phase 2 ZYNERGY trial of petrelintide co-administered with enicepatide in people with obesity or overweight
18/11/2026 -
Novo Nordisk Foundation commits US$60 million to strengthen CARB-X efforts against antimicrobial resistance
18/11/2026 -
Novartis showcases hematology momentum and continued breast cancer leadership at ASH and SABCS
18/11/2026 -
Medline Inc. announces pricing of secondary offering of Class A common stock
18/11/2026 -
Erasca Enters into Clinical Collaboration with Bristol Myers Squibb to Evaluate ERAS-0015 in Clinical Study with Navlimetostat
18/11/2026 -
Portsmouth Square, Inc. Reports First Quarter Fiscal 2027 Results; Pedestrian Bridge Removal Complete and Hotel Reopened After City-Mandated Closure
17/11/2026 -
BioSyent Releases Financial Results for Q3 and YTD 2026
17/11/2026 -
BioSyent Declares Fourth Quarter 2026 Dividend
17/11/2026 -
Biogen’s Diranersen Demonstrates Increasing Clinical Benefit at Two Years in Early Alzheimer’s Disease
17/11/2026 -
InspireMD to Host KOL Webinar on Carotid Artery Disease Management and the Clinical Benefits of InspireMD’s CGuard Prime Carotid Stent Platform
17/11/2026 -
Gain Therapeutics Presents Clinical Data from Phase 1b Study of Rexaceract and Preclinical Data from Novel GCase Modulator GT-04686
17/11/2026 -
CytomX Therapeutics Announces Milestone Achievement in Strategic Collaboration with Regeneron in the Field of Conditionally Activated Bispecifics
17/11/2026 -
CVRx to Participate at the Piper Sandler 38th Annual Healthcare Conference
17/11/2026 -
PacBio to Participate in the Piper Sandler 38th Annual Healthcare Conference
17/11/2026 -
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
17/11/2026 -
Inspire Medical Systems, Inc. to Present at the Piper Sandler 38th Annual Healthcare Conference
17/11/2026 -
Iridex Reports Third Quarter 2026 Financial Results
17/11/2026 -
Mobia Medical to Participate in the Piper Sandler 38th Annual Healthcare Conference
17/11/2026 -
Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
17/11/2026
Pages